Concepedia

Huirong Shi

HS

45

Publications

1.5K

Citations

28

H-Index

2003

Active since

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengzhou University

University of California, Los Angeles

Harvard University

Massachusetts General Hospital

Huirong Shi is an author at First Affiliated Hospital of Zhengzhou University specializing in medicine, ovarian cancer, and cell biology.

ORCID

Top concepts

Publications per year

2003–2022

45

Publications

45

RETRACTED ARTICLE: MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways

Ruitao Zhang, Huirong Shi, Fang Ren et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 63 citations · Full text

Cyclin‐dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer

Jinglu Wang, Dylan C. Dean, Francis J. Hornicek et al. · The FASEB Journal · 2019 · 61 citations · Full text

, , +13

Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells

Ruitao Zhang, Huirong Shi, Zhimin Chen et al. · Journal of Experimental & Clinical Cancer Research · 2011 · 58 citations · Full text

UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway

Minghui Zhang, Huihui Zhang, Xue‐Hua Du et al. · Oncogene · 2019 · 57 citations

, , +9

RETRACTED: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma

Wenlong Feng, Dylan C. Dean, Francis J. Hornicek et al. · Therapeutic Advances in Medical Oncology · 2020 · 55 citations · Full text

Rows per page

1–5 of 45